Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101546 (US8530494, 211 | US8530652, 125 | US8530652, 73) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 1.60 | n/a | n/a | n/a | <3.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101542 (US8530494, 207 | US8530652, 121 | US8530652, 69) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 1.90 | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101479 (US8524710, 56 | US8530652, 50 | US8530652, 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 2.80 | n/a | n/a | n/a | 0.940 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101537 (US8530494, 204 | US8530652, 115 | US8530652, 64) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | <3.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM4838 (US8524710, 83 | US8530494, 13 | US8530652, 52) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 3.5 | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM4838 (US8524710, 83 | US8530494, 13 | US8530652, 52) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 3.5 | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101547 (US8530494, 212 | US8530652, 126 | US8530652, 74) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 3.60 | n/a | n/a | n/a | <3.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101544 (US8530494, 105 | US8530652, 123 | US8530652, 71) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 5.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101548 (US8530494, 108 | US8530652, 127 | US8530652, 75) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 5.20 | n/a | n/a | n/a | <3.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101541 (US8530494, 104 | US8530652, 120 | US8530652, 68) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 6.70 | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101504 (US8524699, 91 | US8524710, 82 | US8530652, 31) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 7.20 | n/a | n/a | n/a | 21 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101549 (US8530494, 109 | US8530652, 128 | US8530652, 76) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 8.30 | n/a | n/a | n/a | <3.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101543 (US8530494, 206 | US8530652, 122 | US8530652, 70) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 8.80 | n/a | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101476 (US8524710, 53 | US8530652, 3 | US8530652, 47) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 11 | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101475 (US8524710, 52 | US8530652, 2 | US8530652, 46) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 14 | n/a | n/a | n/a | 36 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101530 (US8530494, 29 | US8530494, 7 | US8530652, 57) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 14 | n/a | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101535 (US8530494, 104 | US8530652, 113 | US8530652, 62) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 15 | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101515 (US8524699, 26 | US8530652, 42 | US8530670, 31) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 16 | n/a | n/a | n/a | 340 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101545 (US8530494, 107 | US8530652, 124 | US8530652, 72) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 16 | n/a | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101524 (US8530652, 51 | US8530652, 96) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 18 | n/a | n/a | n/a | 31 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101513 (US8524699, 18 | US8530652, 40 | US8530652, 85) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 18 | n/a | n/a | n/a | 98 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101504 (US8524699, 91 | US8524710, 82 | US8530652, 31) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 20 | n/a | n/a | n/a | 103 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101536 (CHEMBL3128043 | US8530494, 203 | US8530652, 114 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Similars | US Patent | 20 | n/a | n/a | n/a | <3.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101507 (US8524710, 86 | US8530652, 34 | US8530652, 79) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 21 | n/a | n/a | n/a | 778 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101534 (US8530494, 202 | US8530652, 112 | US8530652, 61) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 22 | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101514 (US8524699, 22 | US8530652, 41 | US8530652, 86) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 24 | n/a | n/a | n/a | 147 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101518 (US8524699, 46 | US8530652, 45 | US8530652, 90) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 25 | n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101639 (US8530652, 84) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 34 | n/a | n/a | n/a | 455 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101485 (US8524710, 62 | US8530652, 12 | US8530652, 56) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 38 | n/a | n/a | n/a | 78 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101552 (US8530494, 214 | US8530652, 131 | US8530652, 79) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 39 | n/a | n/a | n/a | >3.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101533 (US8530494, 103 | US8530652, 111 | US8530652, 60) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 40 | n/a | n/a | n/a | <3.90 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101556 (US8530652, 1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 41 | n/a | n/a | n/a | >2.00E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101506 (US8524710, 85 | US8530652, 33 | US8530652, 78) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 47 | n/a | n/a | n/a | 618 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101641 (US8530652, 86) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101638 (US8530652, 83) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 58 | n/a | n/a | n/a | 84 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101526 (US8530494, 11 | US8530652, 53 | US8530652, 98) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 67 | n/a | n/a | n/a | 1.75E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101489 (US8524710, 67 | US8530652, 16 | US8530652, 60) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 76 | n/a | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101503 (US8524710, 81 | US8530652, 30 | US8530652, 74) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 80 | n/a | n/a | n/a | 968 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101554 (US8530494, 210 | US8530652, 134 | US8530652, 81) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 84 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101480 (US8524710, 57 | US8530652, 51 | US8530652, 7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 87 | n/a | n/a | n/a | >4.00E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101488 (US8524710, 66 | US8530652, 15 | US8530652, 59) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 90 | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM4827 (US8530652, 20) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 90 | n/a | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101550 (US8530494, 110 | US8530652, 129 | US8530652, 77) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 93 | n/a | n/a | n/a | 69 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101515 (US8524699, 26 | US8530652, 42 | US8530670, 31) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 94 | n/a | n/a | n/a | 610 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101511 (US8524699, 7 | US8530652, 38 | US8530652, 83) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 96 | n/a | n/a | n/a | 1.47E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101640 (US8530652, 85) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101477 (US8524710, 54 | US8530652, 4 | US8530652, 48) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 110 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101483 (US8524710, 60 | US8530652, 10 | US8530652, 54) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 120 | n/a | n/a | n/a | >4.00E+3 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101553 (US8530494, 215 | US8530652, 132 | US8530652, 80) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 120 | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Serine/threonine-protein kinase PAK 4 (Homo sapiens (Human)) | BDBM101527 (US8530494, 12 | US8530652, 105 | US8530652, 54) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 140 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Agouron Pharmaceuticals, Inc.; Pfizer Inc. US Patent | Assay Description The enzymatic activity of PAK4 KD was measured by its ability to catalyzed the transfer of a phosphate residue from a nucleoside triphosphate to an a... | US Patent US8530652 (2013) BindingDB Entry DOI: 10.7270/Q2F18XC4 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 86 total ) | Next | Last >> |